Latest market price
21.23
-1.18-5.27%
Earnings
Down 5.3% — Reported earnings — EPS beat by 38%, revenue beat by 1%.
High confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -0.34 | Insider Own | 6.18% | Shs Outstand | 44.82M | Perf Week | -1.16% |
| Market Cap | 951.50M | Forward P/E | — | EPS next Y | -0.33 | Insider Trans | -10.13% | Shs Float | 42.62M | Perf Month | 15.32% |
| Enterprise Value | 812.50M | PEG | — | EPS next Q | -0.13 | Short Float | 11.04% | Perf Quarter | 15.07% | ||
| Income | -15.00M | P/S | 4.45 | EPS this Y | — | Short Ratio | 8.63 | Perf Half Y | 60.71% | ||
| Sales | 214.00M | P/B | 5.23 | EPS next Y | — | ROA | -5.88% | Short Interest | 4.70M | Perf YTD | 7.66% |
| Book/sh | 4.06 | P/C | 6.52 | EPS next 5Y | — | ROE | -8.23% | 52W High | 22.95 -7.49% | Perf Year | 39.12% |
| Cash/sh | 3.26 | P/FCF | — | EPS past 3/5Y | — | ROIC | -7.88% | 52W Low | 11.48 84.93% | Perf 3Y | 28.20% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 23.77% 22.45% | Gross Margin | 79.53% | Volatility | 4.07% 3.97% | Perf 5Y | -3.76% |
| Dividend TTM | — | EV/Sales | 3.80 | EPS Y/Y TTM | — | Oper. Margin | -8.31% | ATR (14) | 0.81 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 7.55 | Sales Y/Y TTM | 15.68% | Profit Margin | -6.85% | RSI (14) | 58.65 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 9.15 | EPS Q/Q | 35.71% | SMA20 | 4.12% | Beta | 0.64 | Target Price | 23.00 |
| Payout | 0.00% | Debt/Eq | 0.04 | Sales Q/Q | 14.29% | SMA50 | 9.36% | Rel Volume | 2.17 | Prev Close | 22.41 |
| Employees | 376 | LT Debt/Eq | 0.04 | Earnings | Nov 02 | SMA200 | 29.47% | Avg Volume | 575.86K | Price | 21.23 |
| IPO Date | Oct 17, 2018 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 37.53% 1.21% | Net Debt/EBITDA | — | Volume | 1,249,176 | Change | -5.27% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-04-26 | Reiterated | UBS | Buy | $24 → $25 |
| Jul-28-26 | Initiated | UBS | Buy | $24 |
| Jul-16-26 | Reiterated | Truist Securities | Buy | $24 → $21 |
| Feb-24-26 | Reiterated | Truist Securities | Buy | $23 → $24 |
| Dec-18-25 | Reiterated | Truist Securities | Buy | $20 → $23 |
| Dec-17-25 | Reiterated | Canaccord Genuity | Buy | $27 |
| Dec-16-25 | Reiterated | Needham | Buy | $19 → $27 |
| Dec-02-25 | Reiterated | Morgan Stanley | Overweight | $18 → $23 |
| Oct-15-25 | Reiterated | Truist Securities | Buy | $18 → $20 |
| Aug-11-25 | Reiterated | Cantor Fitzgerald | Overweight | $25 |
Latest News· Times ET
Oct-29-26
Oct-29-2605:43PM
Oct-19-26
Oct-19-2604:09PM
Oct-14-26
Oct-12-26
Oct-12-2608:03PM
Oct-06-26
Sep-28-26
Sep-28-2604:09PM
Sep-14-26
Sep-14-2611:31AM
Aug-31-26
Aug-31-2604:09PM
Aug-25-26
Aug-24-26
Aug-24-2610:56AM
Aug-06-26
Aug-06-2610:56AM
Aug-05-26
Aug-04-26
08:09AM
SI-BONE, Inc. (SIBN) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-03-26
Company
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 214 | 201 | 167 | 139 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 44 | 41 | 35 | 29 | — | — | — | — | — | |
| Gross Profit | 171 | 160 | 132 | 109 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 170 | 165 | 151 | 141 | — | — | — | — | — | |
| Research and Development | 17 | 17 | 17 | 15 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | -1 | 0 | — | — | — | — | — | |
| Operating Income | -17 | -22 | -35 | -47 | — | — | — | — | — | |
| Interest Expense | 4 | 5 | 3 | 3 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 4 | 9 | 8 | 7 | — | — | — | — | — | |
| Net Income Before Taxes | -15 | -19 | -31 | -43 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | -15 | -19 | -31 | -43 | — | — | — | — | — | |
| Net Income From Continuing Operations | -15 | -19 | -31 | -43 | — | — | — | — | — | |
| Net Income | -15 | -19 | -31 | -43 | — | — | — | — | — | |
| EPS (Recurring) | -0.34 | -0.44 | -0.75 | -1.13 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.34 | -0.44 | -0.75 | -1.13 | — | — | — | — | — | |
| EPS (Diluted) | -0.34 | -0.44 | -0.75 | -1.13 | — | — | — | — | — | |
| EBITDA | -4 | -11 | -23 | -34 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 4.37 | 4.32 | 3.44 | 5.74 | — | — | — | — | — | |
| Gross Margin | 79.91 | 79.60 | 79.04 | 78.42 | — | — | — | — | — | |
| Operating Margin | -7.94 | -10.95 | -20.96 | -33.81 | — | — | — | — | — | |
| Net Margin | -7.01 | -9.45 | -18.56 | -30.94 | — | — | — | — | — | |
| Shares Outstanding | 44 | 44 | 41 | 38 | — | — | — | — | — | |
| Market Capitalization | 934 | 868 | 575 | 798 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| FRANCIS LAURA | Chief Executive Officer | Oct 12 '26 | Sale | 20.05 | 38,006 | 762,013 | 379,256 | Oct 14 |
| Maheshwari Anshul | Chief Op & Financial Officer | Oct 05 '26 | Sale | 19.50 | 1,731 | 33,755 | 218,235 | Oct 06 |
| Maheshwari Anshul | Chief Op & Financial Officer | Oct 02 '26 | Sale | 18.18 | 3,318 | 60,325 | 219,966 | Oct 06 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Oct 02 '26 | Sale | 18.17 | 3,133 | 56,918 | 270,517 | Oct 06 |
| DUNN JEFFREY W | Director | Oct 01 '26 | Sale | 18.47 | 20,000 | 369,400 | 16,057 | Oct 05 |
| DUNN JEFFREY W | Director | Oct 01 '26 | Option Exercise | 4.68 | 20,000 | 93,600 | 36,057 | Oct 05 |
| DUNN JEFFREY W | Director | Sep 01 '26 | Option Exercise | 4.68 | 20,000 | 93,600 | 36,057 | Sep 03 |
| DUNN JEFFREY W | Director | Sep 01 '26 | Sale | 18.91 | 20,000 | 378,160 | 16,057 | Sep 03 |
| Maheshwari Anshul | Chief Op & Financial Officer | Aug 24 '26 | Sale | 20.11 | 11,636 | 233,971 | 223,284 | Aug 26 |
| FRANCIS LAURA | Chief Executive Officer | Aug 24 '26 | Sale | 20.12 | 25,972 | 522,596 | 291,491 | Aug 26 |
| Maheshwari Anshul | Chief Op & Financial Officer | Aug 21 '26 | Sale | 20.02 | 11,228 | 224,785 | 234,920 | Aug 21 |
| FRANCIS LAURA | Chief Executive Officer | Aug 21 '26 | Sale | 20.02 | 3,923 | 78,538 | 317,463 | Aug 21 |
| FRANCIS LAURA | Chief Executive Officer | Aug 20 '26 | Sale | 19.46 | 51,884 | 1,009,663 | 321,386 | Aug 21 |
| Maheshwari Anshul | Chief Op & Financial Officer | Aug 19 '26 | Sale | 19.55 | 5,747 | 112,354 | 246,148 | Aug 21 |
| FRANCIS LAURA | Chief Executive Officer | Aug 17 '26 | Sale | 18.66 | 14,956 | 279,065 | 490,461 | Aug 18 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.